Senators Kennedy (D-MA) Burr (R-NC) and Roberts (R-KS), among others considering legislation that would severely restrict and possibly deny your access to critical medications.

"This could be potentially devastating, not just to my business but to any business relating to supplements," said Sophy Winnick, a Felton mother of four who has been selling Youngevity products for 10 years. "People better get on the horn about this"

A new attack against health freedom, drug safety, and dietary supplements was launched last week by Senator Edward Kennedy (D-MA) with major support from Michael Enzi (R-WY).  It is called the Food and Drug Administration Revitalization Act (S1082).  This legislation was planned over the past few years working hand-in-glove with the FDA’s dysfunctional management and legal team –

The guidance, for instance, offers “raw vegetable juice” as an example. If it is sold as a food, it is a food. However if it is “intended for use” as anything else, such as a treatment regimen, then it would also be subject to regulation as a drug.

How can an agency regulate intent?

For years, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have continued to censor and engage in heavy-handed attempts to restrict access to supplements and educational information for Americans, even when courts have ruled the public has a right to information about dietary supplements and should judge the merits of health claims for supplements for themselves rather than having the FDA make such decisions.

Efforts continue in state legislatures across the country to force twelve-year old girls to submit to a regimen of vaccines for certain strains of the Human Papilloma Virus, or HPV. This drive to coerce families into submitting to yet another state-mandated round of vaccinations has illustrated just how reckless legislators can be with the health of citizens while bringing to the fore the immense power exercised by drug companies supposedly regulated by the FDA.

The Health Freedom Protection Act, H.R. 2117, introduced by Rep. Ron Paul, M.D., (R-TX), would stop the Food and Drug Administration (FDA) from censoring truthful claims about the curative, preventative, or mitigative effects of dietary supplements

Other critics are lambasting federal agencies for not having done enough to stop Speaker. Stop him from what? Getting on a plane when he had broken no law? Do we really want the government to be able to detain someone simply because he may have a disease that is serious but is not a threat to others? Should a citizen's own government be allowed to turn him away at the border as he seeks to re-enter his country, just because someone decided to place him on an advisory "watch list"? I think not.

Right now is a unique window of opportunity to end the federal government's decades-long stranglehold on research into marijuana's potential as an FDA-approved prescription medicine. On May 15, 2007, DEA Law Judge Mary Ellen Bittner issued an Opinion and Recommended Ruling to DEA in favor of Prof. Craker's application to grow research-grade marijuana at the University of Massachusetts--Amherst. Prof. Craker's facility would end NIDA's decades-long monopoly on the supply of marijuana that can be used in FDA-approved research, and is the focal point of the struggle to bring medical marijuana before the FDA to evaluate whether it meets federal standards for safety and efficacy as a prescription medicine.

The DEA is blocking medical marijuana research -- while citing a lack of research to justify its continuing campaigns against medical marijuana users and state medical marijuana laws.

“There is nothing wrong, unethical, illegal, immoral about any of this. … This is an attack on my fundamental liberty to do our work,” Reynolds told The Associated Press.

"They grabbed the door and jerked it open," says one patient who spoke to KAKE News on a condition of anonymity. "And then they grabbed my left arm and pulled it up behind me. They said we can do this the easy way or the hard way."